QDEL: Underlying growth outside China contrasts with Q3 declines and a new $80M+ savings plan

What happened

Q3 revenue fell 12% year over year, while revenue grew 3% in constant currency after excluding respiratory, China, and U.S. Donor Screening. The company announced a restructuring aimed at more than $80 million in annual savings in 2027, alongside narrowed FY2026 guidance.

Confirmed

Global impact / market context

The savings plan could lower operating costs if implemented, potentially helping offset weaker reported revenue. However, the underlying growth figure excludes several areas, so it does not show broad-based growth across the business; narrowed FY2026 guidance also signals a tighter outlook range, not necessarily improved performance.

Analyst inference

The contrast between falling reported revenue and growth in a narrower set of operations makes the source of performance important for investors. If excluded areas remain weak, cost reductions may support profit but cannot by themselves restore revenue; the article provides no implementation details or revised guidance figures.

Analyst inference

What to watch

1. Look for details on which operations or costs the restructuring targets, since those determine whether the more than $80 million annual savings goal is achievable. Analyst inference
2. Check future results for reported revenue and the same constant-currency measure excluding respiratory, China, and U.S. Donor Screening to assess underlying growth. Analyst inference
3. Compare later FY2026 guidance updates with the narrowed outlook and watch whether the company reports progress toward savings planned for 2027. Analyst inference

Evidence

• Original source link unavailable